French emerging medical technology company CERMA, specialised in the development of innovative and minimally invasive devices in phlebology and oncology, announced the creation of spin-off CERMAVEIN. CERMAVEIN was launched to expand commercialization of its proprietary Steam Vein Sclerosis (SVS
Follow and connect with us on Facebook, Twitter, LinkedIn, Elets video
Recommended for you
